Evidence map›Paper›PMID 26490674›Full record

ArticleBiology open2015

Generation of primitive neural stem cells from human fibroblasts using a defined set of factors.

Takumi Miura, Tohru Sugawara, Atsushi Fukuda, Ryo Tamoto, Tomoyuki Kawasaki, Akihiro Umezawa, Hidenori Akutsu

Open access · goldAbstract read
In one paragraph

Article in Biology open, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Takumi MiuraDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan miura-t@nihs.go.jp akutsu-h@ncchd.go.jp.
Tohru SugawaraDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan.
Atsushi FukudaDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan.
Ryo TamotoDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan.
Tomoyuki KawasakiDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan.
Akihiro UmezawaDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan.
Hidenori AkutsuDepartment of Reproductive Biology, National Center for Child Health and Development, Tokyo 157-8535, Japan Department of Stem Cell Research, Fukushima Medical University, Fukushima 960-1295, Japan miura-t@nihs.go.jp akutsu-h@ncchd.go.jp.
National Center For Child Health and Development · JPFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In mice, leukemia inhibitory factor (LIF)-dependent primitive neural stem cells (NSCs) have a higher neurogenic potential than bFGF-dependent definitive NSCs. Therefore, expandable primitive NSCs are required for research and for the development of therapeutic strategies for neurological diseases. There is a dearth of suitable techniques for the generation of human long-term expandable primitive NSCs. Here, we have described a method for the conversion of human fibroblasts to LIF-dependent primitive NSCs using a strategy based on techniques for the generation of induced pluripotent stem cells (iPSCs). These LIF-dependent induced NSCs (LD-iNSCs) can be expanded for >100 passages. Long-term cultured LD-iNSCs demonstrated multipotent neural differentiation potential and could generate motor neurons and dopaminergic neurons, as well as astrocytes and oligodendrocytes, indicating a high level of plasticity. Furthermore, LD-iNSCs easily reverted to human iPSCs, indicating that LD-iNSCs are in an intermediate iPSC state. This method may facilitate the generation of patient-specific human neurons for studies and treatment of neurodegenerative diseases.

Indexed as

Neural stem cellReprogrammingStem cells

Identifiers

PMID26490674
PMCPMC4728346
OpenAlexW2176954042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.